Hemosure is established upon over a decade of research in the bio-technological industry. Its scientific professional team has applied these years of R&D experience to their development of one-step membrane immunoassay tests. With the strong support of our sister company, WHPM, Hemosure has continuously researched, developed, and produced high quality rapid test systems that have not only revolutionized the pharmaceutical industry, but have also set new industry standards and guidelines.

Our current product leader is Hemosure^®, a trade name recognized worldwide in immunological fecal occult blood test (IFOBT). In year 2001, Hemosure was proudly designated a sponsor in providing high quality immunological fecal occult blood tests for a large colorectal cancer-screening program; over 20,000 people in Beijing, China took part in the study. In April 2004, the Company sponsored another colorectal cancer-screening program in Hangzhou, China, in which over 60,000 people participated. Upon completion, these two recent studies together will surpass any previous clinically related studies in the world in terms of size and scope.